P2 Capital Partners Upped By $10.70 Million Its Cbiz (CBZ) Holding, Novogen Limited Ads (NVGN) Shorts Raised By 117.5%

June 6, 2017 - By Maria Brooks

P2 Capital Partners Llc increased Cbiz Inc (CBZ) stake by 140.49% reported in 2016Q4 SEC filing. P2 Capital Partners Llc acquired 822,856 shares as Cbiz Inc (CBZ)’s stock rose 10.70%. The P2 Capital Partners Llc holds 1.41 million shares with $19.30 million value, up from 585,716 last quarter. Cbiz Inc now has $799.74 million valuation. It is 0.00% or $0 reaching $14.95 per share. It is down 47.49% since June 6, 2016 and is uptrending. It has outperformed by 30.79% the S&P500.

Novogen Limited Ads (NASDAQ:NVGN) had an increase of 117.5% in short interest. NVGN’s SI was 26,100 shares in June as released by FINRA. Its up 117.5% from 12,000 shares previously. With 35,000 avg volume, 1 days are for Novogen Limited Ads (NASDAQ:NVGN)’s short sellers to cover NVGN’s short positions. The SI to Novogen Limited Ads’s float is 0.15%. About 35,420 shares traded or 25.82% up from the average. Novogen Limited (ADR) (NASDAQ:NVGN) has declined 55.51% since June 6, 2016 and is downtrending. It has underperformed by 72.21% the S&P500.

Investors sentiment decreased to 0.93 in 2016 Q4. Its down 0.59, from 1.52 in 2016Q3. It worsened, as 11 investors sold CBZ shares while 43 reduced holdings. 8 funds opened positions while 42 raised stakes. 45.05 million shares or 0.48% less from 45.27 million shares in 2016Q3 were reported. Mariner Wealth Advsrs Limited Co accumulated 11,308 shares. Bessemer Grp has invested 0% in CBIZ, Inc. (NYSE:CBZ). Kistler owns 5,000 shares. Aqr Management Limited Liability Corporation invested in 0% or 29,197 shares. Susquehanna International Group Llp invested in 76,655 shares or 0% of the stock. 99,985 are owned by Millennium Llc. Cornercap Invest Counsel owns 0.12% invested in CBIZ, Inc. (NYSE:CBZ) for 50,835 shares. Northern Tru holds 811,342 shares. Oxford Asset Management invested in 0.03% or 38,188 shares. Boston Partners holds 0% or 271,570 shares. Rhumbline Advisers holds 66,297 shares or 0% of its portfolio. Brown Advisory reported 16,010 shares. Qs Investors Limited Liability Company holds 0% or 30 shares. The New York-based Int Gp Incorporated has invested 0% in CBIZ, Inc. (NYSE:CBZ). Bridgeway owns 270,900 shares.

Among 2 analysts covering CBIZ (NYSE:CBZ), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. CBIZ had 6 analyst reports since October 7, 2015 according to SRatingsIntel. The rating was upgraded by First Analysis to “Equal-Weight” on Tuesday, March 15. The company was downgraded on Tuesday, October 13 by Sidoti. The company was downgraded on Thursday, October 29 by First Analysis. Sidoti upgraded the stock to “Buy” rating in Thursday, January 21 report. The rating was initiated by Sidoti on Tuesday, July 19 with “Buy”. The firm has “Equal-Weight” rating given on Wednesday, October 7 by First Analysis.

Since December 13, 2016, it had 0 insider purchases, and 11 insider sales for $3.61 million activity. Shares for $120,040 were sold by GLEESPEN MICHAEL W on Thursday, May 18. GERARD STEVEN L also sold $349,265 worth of CBIZ, Inc. (NYSE:CBZ) shares. 20,000 shares were sold by WEIR DONALD V, worth $269,800. 12,000 shares were sold by GROVE WARE H, worth $182,836. $145,532 worth of stock was sold by DIMARTINO JOSEPH S on Tuesday, February 21. SLOTKIN TODD J sold 8,500 shares worth $115,265.

Novogen Limited is an oncology biotechnology company, which is focused on developing cancer treatments. The company has market cap of $12.51 million. The Firm is primarily engaged in pharmaceutical research and development. It currently has negative earnings. Novogen has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding various drug candidates across a range of oncology indications.

Investors sentiment decreased to 0.75 in 2016 Q4. Its down 2.25, from 3 in 2016Q3. It dived, as 2 investors sold Novogen Limited (ADR) shares while 2 reduced holdings. 2 funds opened positions while 1 raised stakes. 236,774 shares or 28.65% less from 331,844 shares in 2016Q3 were reported. Renaissance Techs Limited Liability Corp invested 0% in Novogen Limited (ADR) (NASDAQ:NVGN). Royal National Bank & Trust Of Canada invested 0% of its portfolio in Novogen Limited (ADR) (NASDAQ:NVGN). New York-based Morgan Stanley has invested 0% in Novogen Limited (ADR) (NASDAQ:NVGN). Creative Planning invested in 0% or 200 shares. Bancorp Of America De holds 220 shares. Tower Rech Cap Ltd (Trc) holds 100 shares.